KA/EN
Register
Medicines reference
Search
Search
Product

AMOXY 150

Favourites

Amoxicillin · Hebei Lihua Pharmaceutical

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

Form Dose Frequency Georgia
Suspension No label dose in the reference yet - Georgia Yes, veterinary
In force until 09 Jun 2028
Veterinary (National Food Agency)
In the register: ამოქსიცილინი 150
№ 000350
Verified on: 22 Oct 2026
Details: pack, label wording, sources, registration

AMOXY 150, Suspension

Amoxicillin 150 mg/ml, suspension for injection
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Proposed injectable treatment of a susceptible bacterial infection in a dog or cat with exact Hebei Lihua AMOXY 150; the current exact public product information does not include either species.
Not rateable
No numerical score assigned
vetman assessment

AMOXY 150

Amoxicillin 150 mg/ml, suspension for injection
Assessed clinical scopeDog · Proposed injectable treatment of a susceptible bacterial infection in a dog or cat with exact Hebei Lihua AMOXY 150; the current exact public product information does not include either species. · SC,IM
Care settingNot an established dog/cat pathway; another amoxicillin product with an exact companion-animal label should be selected instead of extrapolating by concentration
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Yes, veterinary · № 000350 · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical dog/cat score cannot responsibly be calculated for this exact product. The Georgian register confirms Amoxicillin 150 by Hebei Lihua, but the old dog/cat statement and 7 mg/kg daily dose were borrowed from Norbrook Betamox rather than this product. Current Hebei Lihua information and an official Vietnamese imported-product record identify AMOXY 150 for cattle, goats, sheep and pigs only, with a different 15 mg/kg long-acting schedule. Equal 150 mg/ml concentration does not bridge formulation, excipients, target species, dose interval, safety or efficacy. Exact dog/cat label and outcome data are missing.

This is a documented veterinary product, but not a scoreable dog/cat presentation on current exact evidence. Its Georgian registration remains visible; the responsible correction is to block the borrowed calculator dose and disclose the species/formulation gap, not to invent a low score.

Important safety and use flags

  • Use only for a diagnosed or strongly supported bacterial infection caused by organisms likely to be susceptible to amoxicillin. Obtain culture and susceptibility whenever feasible and narrow or stop treatment when results do not support it.
  • This exact Hebei Lihua AMOXY 150 is not Betamox. Do not copy another 150 mg/ml product dose merely because concentration and active ingredient match; target species, oil vehicle, release profile and interval require exact-form evidence.
  • No dog or cat dose is established for this exact product. The calculator block is intentional; use a companion-animal-labelled alternative rather than the food-animal 15 mg/kg schedule or the borrowed Betamox 7 mg/kg schedule.
  • Do not use in a patient with known penicillin or cephalosporin hypersensitivity. Cross-reaction, urticaria and anaphylaxis are possible; stop treatment and provide emergency care for facial swelling, dyspnoea, hypotension or collapse.
  • Amoxicillin is ineffective against beta-lactamase-producing organisms and resistant isolates. Methicillin-resistant staphylococci, Pseudomonas and other intrinsically or acquired-resistant pathogens must not be inferred susceptible from a broad label list.
  • Review concurrent antimicrobials. Do not routinely combine a bactericidal beta-lactam with bacteriostatic tetracyclines, macrolides, chloramphenicol, lincosamides or sulfonamides without a documented microbiologic and clinical rationale.
  • Use aseptic technique and prevent accidental self-injection. Penicillin-sensitised staff should not handle the product; human rash requires medical advice, while facial/lip/eye swelling or breathing difficulty requires urgent medical attention.
  • Exact dog/cat injection-site tolerance, maximum site volume, repeat-site guidance and preservative/in-use handling are not established publicly for this product. Do not infer them from the food-animal page or Betamox.
  • The current public exact-product material lists food animals and withdrawal periods, not dogs or cats. Georgian registration alone does not supply the missing companion-animal benefit-risk bridge.
  • Reassess clinical response within 48 hours, including source control and the possibility of a nonbacterial diagnosis. Avoid prophylactic or unnecessarily prolonged exposure; aminopenicillins are EMA Category D (Prudence), not resistance-free.
Assessment sources
  1. Lihua amoxicillin 15%2026
  2. AMOXY 150 official register2026
  3. Amoxicillin injections GE register2026
  4. Betamox LA VMD SPC2025
  5. Clamoxyl LA VMD label2022
  6. Canine LA amoxicillin PK/PD2024
  7. Feline amoxicillin PK2025
  8. EMA AMEG Category D2019
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Proposed injectable treatment of a susceptible bacterial infection in a dog or cat with exact Hebei Lihua AMOXY 150; the current exact public product information does not include either species.
Not rateable
No numerical score assigned
vetman assessment

AMOXY 150

Amoxicillin 150 mg/ml, suspension for injection
Assessed clinical scopeCat · Proposed injectable treatment of a susceptible bacterial infection in a dog or cat with exact Hebei Lihua AMOXY 150; the current exact public product information does not include either species. · SC,IM
Care settingNot an established dog/cat pathway; another amoxicillin product with an exact companion-animal label should be selected instead of extrapolating by concentration
vetman score Not rateable No numerical score assigned
Evidence confidence: Medium Georgia: Yes, veterinary · № 000350 · Verified on 22 Oct 2026 Off-label use
Not rateable

A numerical dog/cat score cannot responsibly be calculated for this exact product. The Georgian register confirms Amoxicillin 150 by Hebei Lihua, but the old dog/cat statement and 7 mg/kg daily dose were borrowed from Norbrook Betamox rather than this product. Current Hebei Lihua information and an official Vietnamese imported-product record identify AMOXY 150 for cattle, goats, sheep and pigs only, with a different 15 mg/kg long-acting schedule. Equal 150 mg/ml concentration does not bridge formulation, excipients, target species, dose interval, safety or efficacy. Exact dog/cat label and outcome data are missing.

This is a documented veterinary product, but not a scoreable dog/cat presentation on current exact evidence. Its Georgian registration remains visible; the responsible correction is to block the borrowed calculator dose and disclose the species/formulation gap, not to invent a low score.

Important safety and use flags

  • Use only for a diagnosed or strongly supported bacterial infection caused by organisms likely to be susceptible to amoxicillin. Obtain culture and susceptibility whenever feasible and narrow or stop treatment when results do not support it.
  • This exact Hebei Lihua AMOXY 150 is not Betamox. Do not copy another 150 mg/ml product dose merely because concentration and active ingredient match; target species, oil vehicle, release profile and interval require exact-form evidence.
  • No dog or cat dose is established for this exact product. The calculator block is intentional; use a companion-animal-labelled alternative rather than the food-animal 15 mg/kg schedule or the borrowed Betamox 7 mg/kg schedule.
  • Do not use in a patient with known penicillin or cephalosporin hypersensitivity. Cross-reaction, urticaria and anaphylaxis are possible; stop treatment and provide emergency care for facial swelling, dyspnoea, hypotension or collapse.
  • Amoxicillin is ineffective against beta-lactamase-producing organisms and resistant isolates. Methicillin-resistant staphylococci, Pseudomonas and other intrinsically or acquired-resistant pathogens must not be inferred susceptible from a broad label list.
  • Review concurrent antimicrobials. Do not routinely combine a bactericidal beta-lactam with bacteriostatic tetracyclines, macrolides, chloramphenicol, lincosamides or sulfonamides without a documented microbiologic and clinical rationale.
  • Use aseptic technique and prevent accidental self-injection. Penicillin-sensitised staff should not handle the product; human rash requires medical advice, while facial/lip/eye swelling or breathing difficulty requires urgent medical attention.
  • Exact dog/cat injection-site tolerance, maximum site volume, repeat-site guidance and preservative/in-use handling are not established publicly for this product. Do not infer them from the food-animal page or Betamox.
  • The current public exact-product material lists food animals and withdrawal periods, not dogs or cats. Georgian registration alone does not supply the missing companion-animal benefit-risk bridge.
  • Reassess clinical response within 48 hours, including source control and the possibility of a nonbacterial diagnosis. Avoid prophylactic or unnecessarily prolonged exposure; aminopenicillins are EMA Category D (Prudence), not resistance-free.
Assessment sources
  1. Lihua amoxicillin 15%2026
  2. AMOXY 150 official register2026
  3. Amoxicillin injections GE register2026
  4. Betamox LA VMD SPC2025
  5. Clamoxyl LA VMD label2022
  6. Canine LA amoxicillin PK/PD2024
  7. Feline amoxicillin PK2025
  8. EMA AMEG Category D2019
Assessed: 22 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Amoxicillin150 mg/ml
Formulation Type
Suspension
Administration route
Subcutaneous, Intramuscular
Manufacturer
Hebei Lihua Pharmaceutical · China
Manufacturer (register)
Hebei Lihua Pharmaceutical Co. Ltd, China
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 846, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 09 Jun 2028
Veterinary (National Food Agency)
In the register: ამოქსიცილინი 150
№ 000350
Verified on: 22 Oct 2026
 EU Not confirmed
Verified on: 22 Oct 2026
 UK Not confirmed
Verified on: 22 Oct 2026
 US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified No dog or cat dose is published for exact Hebei Lihua AMOXY 150. Current exact public material identifies food-animal species only; do not transfer another 150 mg/ml amoxicillin regimen by concentration alone.

Amoxicillin: No dose supported by a publicly verifiable source yet

Known Contraindications

  • Critical
    Do not use in cases of hypersensitivity to the active substances, other substances of the beta-lactam group or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical
    Do not use in animals with severe renal impairment with anuria or oliguria.
    Sources: VMD SPC · VMD
  • Warning
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD SPC · VMD
  • Warning
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD SPC · VMD

Known Drug Interactions

  • Major warning Amoxicillin + Doxycycline
    The bactericidal effect of amoxicillin may be inhibited by the concomitant use of bacteriostatic antimicrobials.
    Recommendation: If both are required, support the choice with culture and susceptibility results. Otherwise, choose one mechanism.
    Sources: VMD SPC · VMD
  • Major warning Amoxicillin + Oxytetracycline
    Do not give oxytetracycline at the same time as bactericidal antimicrobials such as penicillins or cephalosporins because their antibacterial effects may be antagonistic.
    Recommendation: Do not administer concurrently.
  • Minor warning Amoxicillin + Dihydrostreptomycin
    Penicillins may increase the effect of aminoglycosides.
    Recommendation: An enhanced effect is expected; monitor for aminoglycoside toxicity. Do not mix in the same syringe.
    Sources: VMD SPC · VMD
  • Minor warning Amoxicillin + Trimethoprim/Sulfonamide
    Concurrent use of bactericidal beta-lactam antibiotics and bacteriostatic antimicrobials such as sulfonamides is generally not recommended because their effects may be antagonistic.
    Recommendation: Avoid concomitant administration.

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (59 more) Hide additional products

Same therapeutic group 59

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 22 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗